Maloprim® malaria prophylaxis in children living in a holoendemic village in north-eastern Tanzania

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 91, Issue 1, 1997, Pages 68-73

  Lemnge, M M ^a,b,c   Msangeni, H A ^a   Ronn A M ^b   Salum, F M ^a   Jakobsen, P H ^b   Mhina, J I ^a   Akida, J A ^a   Bygbjerg, I C ^b  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

^b Rigshospitalet   (Denmark)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

Author keywords

Maloprim ; Plasmodium falciparum; Prophylaxis; Tanzania

Indexed keywords

ANTIMALARIAL AGENT; DAPSONE; MALOPRIM; PYRIMETHAMINE; ANTIINFECTIVE AGENT;

ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENDEMIC DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; MALE; PARASITE TRANSMISSION; PARASITEMIA; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SPLENOMEGALY; TANZANIA; BLOOD; COHORT ANALYSIS; DRUG COMBINATION; DRUG RESISTANCE; FEVER; FOLLOW UP; HEMATOCRIT; INFANT; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ANTI-INFECTIVE AGENTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DAPSONE; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; DRUG RESISTANCE; FEMALE; FEVER; FOLLOW-UP STUDIES; HEMATOCRIT; HUMANS; INFANT; MALARIA; MALE; PARASITEMIA; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; PYRIMETHAMINE; SPLENOMEGALY; TANZANIA; TREATMENT OUTCOME;

EID: 0030611072     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(97)90401-6     Document Type: Article

References (18)

1. Clyde, D. F. & Shute, G. T. (1957). Resistance of Plasmodium falciparum in Tanganyika to pyrimethamine administered at weekly intervals. Transactions of the Royal Society of Tropical Medicine and Hygiene, 51, 505-513.
2. Dacie, J. V. & Lewis, S. M. (1985). Practical Haematology, 6th edition. London: Churchill Livingstone.
3. Desjardins, R. E., Doberstyn, E. B. & Wernsdorfer, W. H. (1988). The treatment and prophylaxis of malaria. In: Malaria. Principles and Practice of Malariology, vol. 1, Wernsdorfer, W. H. & McGregor, I. (editors). Edinburgh: Churchill Livingstone. pp. 852-854.
4. Greenwood, B. M. (1987). Asymptomatic malaria infections - do they matter? Parasitology Today, 3, 206-214.
5. Greenwood, B. M. (1991). Malaria chemoprophylaxis in endemic regions. In: Waiting for the Vaccine, Targett, G. A. T. (editor). Chichester: John Wiley & Sons, pp. 83-102.
6. Greenwood, B. M., Greenwood, A. M., Bradley, A. K., Snow, R. W., Byass, P., Hayes, R. J. & N'Jie, A. B. H. (1988). Comparison of two strategies for control of malaria within a primary health care programme in The Gambia. Lancet, i, 1121-1127.
7. Greenwood, B. M., Greenwood, A. M., Smith, A. W., Menon, A., Bradley, A. K., Snow, R. W., Sisay, F., Bennett, S., Watkins, W. M. & N'Jie, A. B. H. (1989). A comparative study of Lapudrine® (chlorproguanil) and Maloprim® (pyrimethamine and dapsone) as chemoprophylactics against malaria in Gambian children. Transactions of the Royal Society of Tropical Medicine and Hygiene, 83, 182-188.
8. Hogh, B., Thompson, R., Lobo, V., Dgedge, M., Dziegiel, M., Borre, M., Gottschau, A., Streat, E., Schapira, A. & Barreto, J. (1994).The influence of Maloprim chemoprophylaxis on cellular and humoral immune responses to Plasmodium falciparum asexual blood stage antigens in schoolchildren living in a malaria endemic area of Mozambique. Acta Tropica, 57, 265-277.
9. Kilimali, V. A. E. B. & Mkufya, A. R. (1985). In vivo and in vitro assessment of the sensitivity of Plasmodium falciparm to chloroquine in four districts of Tanga region, Tanzania. Transactions of the Royal Society of Tropical Medicine and Hygiene, 79, 478-481.
10. Lelijveld, J. (1968). Malaria prophylaxis in a school-population in north eastern Tanzania, with the combination of pyrimethamine and diaphenyl-sulfone (Maloprim). In: Annual Report. Amani, Tanzania: East African Institute of Malaria and Vector-Borne Diseases, pp. 15-16.
11. Lines, J. & Armstrong, J. R. M. (1992). For a few parasites more: inoculum size, vector control and strain-specific immunity to malaria. Parasitology Today, 8, 381-383.
12. Lucas, A. O., Hendrickse, G., Okubadejo, O. A., Richards, W. H. G., Neal, R. A. & Kofie, B. A. K. (1969). The suppression of malarial parasitaemia by pyrimethamine in combination with dapsone or sulphormethoxine. Transactions of the Royal Society of Tropical Medicine and Hygiene, 63, 216-229.
13. Lyimo, E. O., Msuya, F. H. M., Rwegoshora, R. T., Nicholson, E. A., Mnzava, A. E. P., Lines, J. D. & Curtis, C. F. (1991). Trial of pyrethroid impregnated bednets in an area of Tanzania holoendemic for malaria. Part 3. Effects on the prevalence of malaria parasitaemia and fever. Acta Tropica, 49, 157-163.
14. Menon, A., Snow, R. W., Byass, P., Greenwood, B. M., Hayes, R. J. & N'Jie, A. B. H. (1990). Sustained protection against mortality and morbidity from malaria in rural Gambian children by chemoprophylaxis given by village health workers. Transactions of the Royal Society of Tropical Medicine and Hygiene, 84, 768-772.
15. Molineaux, L. & Gramiccia, G. (1980). The Garki Project. Geneva: World Health Organization.
16. Rønn, A. M., Msangeni, H. A., Mhina, J., Wernsdorfer, W. & Bygbjerg, I. C. (1996). High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania. Transactions of the Royal Society of Tropical Medicine and Hygiene, 90, 179-181.
17. Smith, T., Armstrong Schellenberg, J. & Hayes, R. (1994). Attributable fraction estimates and case definition for malaria in endemic areas. Statistics in Medicine, 13, 2345-2358.
18. Watkins, W. M. & Masobo, M. (1993). Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life. Transactions of the Royal Society of Tropical Medicine and Hygiene, 87, 75-78.